Menu
Live News EQUITY L impact

Alterity Therapeutics Files 6-K

Alterity Therapeutics submits periodic report to SEC. The report may contain updates on the company's financials or operations.

ATHE

Filed: 2026-05-29 AccNo: 0001437749-26-018808 Size: 216 KB